Author

Qihong Zhao

Bristol-Myers Squibb (United States)ORCID 0000-0003-0542-7954Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Qihong Zhao1 paper · Peter MacCallum Cancer Centre

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Brian L. BressleriD· 1 shared Bruce Andrew VallanceiD· 1 shared Dominic A. BoardmaniD· 1 shared Ho Pan ShamiD· 1 shared Karoliina TuomelaiD· 1 shared Lihong ChengiD· 1 shared Maria Ancheta-Schmit· 1 shared Mary D. Struthers· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Brian L. BresslerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyCell Reports MedicinePeer-reviewedAug 19, 2025

TYK2 inhibition enhances Treg differentiation and function while preventing Th1 and Th17 differnetiation

Karoliina Tuomela, Rosa García, Dominic A. Boardman…·Megan K. Levings

This study shows that TYK2 inhibition promotes Treg differentiation and function while inhibiting Th1 and Th17 differentiation, suggesting its potential for tolerance induction.

14 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky